Century Health has partnered with Arizona Gastrointestinal Associates (AGA) to use AI to convert unstructured clinical data—including endoscopy reports, pathology findings, physician notes, and lab results—into research-grade datasets for inflammatory bowel disease (IBD) and metabolic dysfunction-associated steatohepatitis (MASH). The collaboration leverages Century Health’s AI platform, CHARM, to automate data extraction and analysis, reducing the need for time-consuming manual chart reviews while enabling large-scale real-world evidence generation.
The partnership will analyze data from more than 21,000 IBD and MASH patients treated across AGA’s independent gastroenterology network. By capturing treatment patterns, disease progression, and outcomes from routine clinical practice, the initiative aims to support pharmaceutical research, accelerate drug development, and improve understanding of how therapies perform outside controlled clinical trials. The collaboration also highlights the growing role of AI in unlocking valuable clinical insights from community gastroenterology practices that have historically been difficult to study at scale.